Finance

Lists
Why is CLN down 2,16%?
Dive Deeper
CLN:WSE
Celon Pharma SA
16,30 PLN
-2,16%
(-0,36) 1D
6-ноя., 17:04:09 GMT+1  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
16,40 PLN
High
16,86 PLN
Low
16,16 PLN
Mkt. cap
878,76 млн
Avg. vol.
23,82 миң
Volume
31,07 миң
P/E ratio
7,94
52-wk high
23,50 PLN
52-wk low
15,92 PLN
EPS
2,05 PLN
Shares outstanding
53,91 млн
No. of employees
560
Open
16,40 PLN
High
16,86 PLN
Low
16,16 PLN
Mkt. cap
878,76 млн
Avg. vol.
23,82 миң
Volume
31,07 миң
P/E ratio
7,94
52-wk high
23,50 PLN
52-wk low
15,92 PLN
EPS
2,05 PLN
Shares outstanding
53,91 млн
No. of employees
560
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Next call 10 күндөн кийин
18-ноя., шарш., 06:35
Fiscal period
Q3 2026
- / -
Revenue / Est. (PLN)
- / 63,50 млн
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
71,13 млн
66,67 млн
65,26 млн
55,57 млн
Cost of goods sold
16,83 млн
11,54 млн
16,70 млн
14,92 млн
Cost of revenue
16,83 млн
11,54 млн
16,70 млн
14,92 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,02 млн
35,44 млн
36,08 млн
38,62 млн
Operating expense
46,24 млн
52,60 млн
54,54 млн
50,11 млн
Total operating expenses
63,07 млн
64,14 млн
71,23 млн
65,04 млн
Operating income
8,06 млн
2,53 млн
-5,98 млн
-9,46 млн
Other non operating income
-30,00 миң
-250,00 миң
169,05 млн
3,48 млн
EBT including unusual items
-2,77 млн
-6,57 млн
160,34 млн
-7,38 млн
EBT excluding unusual items
-2,77 млн
-6,57 млн
160,34 млн
-7,38 млн
Income tax expense
-6,43 млн
18,33 млн
1,70 млн
23,21 млн
Effective tax rate
232,29%
-279,14%
1,06%
-314,48%
Other operating expenses
2,20 млн
6,37 млн
7,33 млн
1,36 млн
Net income
3,66 млн
-24,90 млн
158,64 млн
-30,59 млн
Net profit margin
5,15%
-37,35%
243,09%
-55,05%
Earnings per share
-
-
-
-
Interest and investment income
-
149,00 миң
151,00 миң
151,00 миң
Interest expense
-
-341,00 миң
-915,00 миң
-1,55 млн
Net interest expenses
-
-192,00 миң
-764,00 миң
-1,40 млн
Depreciation and amortization charges
11,01 млн
10,78 млн
11,13 млн
10,13 млн
EBITDA
16,34 млн
11,40 млн
3,44 млн
-748,00 миң
Gain or loss from assets sale
-170,00 миң
-2,91 млн
-569,00 миң
716,00 миң
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору